DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hilton Lac-Leamy

2025 年 10 月 27 日 7:30 上午 - 2025 年 10 月 28 日 3:40 下午

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

亮点与特色

What is happening at Canada Annual Meeting



Need Approval in Order to Attend?

Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.



  • Bring together regulators, industry, patients, and academia to exchange perspectives on Canada’s role in global regulatory science
  • Highlight the latest developments in regulation, safety, labeling, trial modernization, and digital transformation
  • Strengthen partnerships between Health Canada, international regulators, industry leaders, and patient representatives
  • Provide learning opportunities across regulatory, clinical, and safety domains to expand participant knowledge and expertise
  • Create space for peer-to-peer exchange through plenaries, breakouts, and dedicated networking sessions

  • Direct access to Health Canada leadership and global regulators
  • Timely updates on evolving regulations, policies, and compliance frameworks
  • Patient-centered perspectives that put lived experience at the heart of discussions
  • Cutting-edge insights on AI, digital submissions, and innovative clinical research models
  • Opportunities to connect with diverse stakeholders across the life sciences ecosystem


Three Educational Tracks: Regulatory, Clinical, Safety and Pharmacovigilance


Track A: Regulatory

The regulatory track provides opportunities for information sharing, use cases, and best practices relating to Canada’s regulatory landscape as it applies to regulatory requirements, new developments, and innovation for life sciences R&D.

Track B: Clinical

Today, modern pharmaceutical, medical device, and diagnostic products are advancing at an unprecedented speed. Sessions in this track will focus on clinical research development and operations for industry.

Track C: Safety and Pharmacovigilance

Our safety and pharmacovigilance track will provide a comprehensive overview of Canada’s regulatory environment in the field of clinical safety and pharmacovigilance for pharmaceutical products and medical devices.


Short Course: ICH E6(R3) in Practice: Canadian Perspective from Health Canada GCP Inspectors

October 16, 2025 – 10:00AM – 1:15PM ET | Virtual
*Short Courses require an additional registration fee. You do not need to be registered for the forum to attend*
The International Council for Harmonisation (ICH) E6 guideline is the global standard for Good Clinical Practice (GCP) in human clinical trials. The recently updated ICH E6(R3) introduces key changes aimed at enhancing trial quality, participant safety, and data integrity. This short course provides an overview of how Health Canada will align its inspection processes and compliance expectation with the revised guideline.

Short Course: Tools and Methods to Evaluate the Effectiveness of Risk Minimization Measures

October 22, 2025 – 10:00AM – 2:00PM ET | Virtual
*Short Courses require an additional registration fee. You do not need to be registered for the forum to attend*
There is an increasing number of risk minimization programs that are implemented in Canada and elsewhere, ranging from communication to mandatory trainings and controlled distribution, amongst others. Although these programs carry enormous relevance for patients and public health, determining whether these programs are effective is methodologically challenging. Methodological and regulatory guidances are available, which must be adapted to the Canadian context.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。